![]() |
市場調查報告書
商品編碼
1955074
全球自動驗光儀和角膜曲率計市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析以及未來預測(2026-2034)Autorefractor and Keratometer Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球自動驗光儀和角膜曲率計市場規模為7326萬美元,預計將從2026年的7710萬美元成長到2034年的1.2019億美元,預測期內年複合成長率(CAGR)為5.71%。北美在先進的醫療基礎設施和眼科診斷技術的積極應用的支持下,在2025年引領市場。
自動驗光儀和角膜曲率計是測量屈光不正和角膜曲率的重要眼科儀器。自動驗光儀透過評估進入眼睛的光線變化來確定屈光不正,而角膜曲率計則測量角膜曲率。一種名為自動屈光角膜曲率計(ARK)的混合設備整合了這兩種功能,可在單一系統中提供全面的眼科檢查。
遠視、近視、散光、白內障和糖尿病視網膜病變等眼部疾病的日益普遍,是全球先進診斷設備需求的主要驅動因素。市場上的主要參與者包括Topcon Corporation、NIDEK CO., Ltd.、Carl Zeiss Meditech AG、EssilorLuxottica、CANON MEDICAL SYSTEMS CORPORATION。
市場驅動因素
眼部疾病盛行率上升
視力障礙發生率的上升是推動市場成長的主要因素。生活方式的改變、螢幕使用時間的增加、人口老化以及糖尿病的增加都導致了屈光不正發病率的上升。全球研究預測,到2050年,近視將影響全球近一半的人口。
各國政府和醫療機構強調早期診斷和預防性眼科護理。定期眼科檢查和相關意識提升計畫推動醫院和診所更多地使用自動驗光儀和角膜曲率計,促進市場穩步擴張。
市場限制因子
認知度低和設備成本高
儘管技術不斷進步,但中低收入國家對定期眼科檢查的認知度仍然有限,這限制了市場成長。此外,高階自動驗光儀的價格可能超過 25,000 美元,這使得小型醫療機構難以負擔。
尤其是在資源匱乏的地區,對價格的擔憂以及因缺乏認知而導致的診斷延誤可能會阻礙設備的普及。
市場機會
策略聯盟與技術創新
主要參與者之間日益增多的聯盟、併購創造成長機會。各公司正投資研發便攜式和人工智慧整合診斷設備。
例如,Carl Zeiss Meditech AG透過收購加強了其眼科產品組合,目的是提升數位化工作流程和先進的診斷能力。手持式和自動化設備的進步預計將推動已開發市場和新興市場的產品普及。
市場挑戰
熟練眼科醫師短缺
訓練有素的眼科醫生和專家短缺是一項重大挑戰。這種勞動力失衡限制了先進診斷設備的有效使用,尤其是在農村地區和醫療服務不足的地區。這可能會減少患者及時獲得眼科診斷和治療的機會。
市場趨勢
人工智慧與數位科技的融合
技術創新顯著改變診斷格局。現代自動驗光儀和角膜曲率計配備了數位顯示器、自動對焦、高解析度成像、雲端連接和電子健康記錄(EHR)相容性。
人工智慧(AI)和機器學習(ML)的融合實現了即時分析和精準診斷。這些創新技術提高了白內障、圓錐角膜和輕微角膜異常的檢測精度,加速了它們在眼科實踐中的應用。
新冠疫情的影響
由於患者就診量減少和選擇性檢測的推遲,新冠疫情對市場成長產生了負面影響。多家公司在2020年經歷了收入下滑。然而,隨著醫療服務在2021年重新開放,患者就診量恢復,市場也逐漸恢復到疫情前的成長軌跡。
依產品類型
市場依產品類型分為自動驗光儀、角膜曲率計和混合型設備。
由於其高精度和雙重功能,混合型設備(ARK)預計將保持主導地位。由於人工智慧增強了相關功能,自動驗光儀市場預計將穩定成長。
便攜性
依便攜性,市場分為桌上型和便攜式兩大類。
台式市場佔據主導地位,這得益於其在眼科診所和醫院的廣泛應用。便攜式市場快速成長,這主要受行動診所和本地支援計畫對便攜式診斷解決方案的需求所驅動。
依適應症
市場涵蓋遠視、近視、散光及其他適應症。
2024年,由於成人和兒童遠視盛行率的上升,遠視市場將佔據較大佔有率。隨著數位設備使用量的增加,近視預計將持續成長。
依最終使用者劃分
市場依最終使用者分為醫院、眼科診所和其他機構。
到2024年,醫院成為市場的主要驅動力,這主要得益於醫院龐大的病患群體和先進設備的普及。由於專業眼科醫療機構的增加,眼科診所預計將以最高的年複合成長率成長。
北美
北美在2025年以2,665萬美元的市場規模引領市場。強有力的償付政策、糖尿病患者數量的增加以及先進的醫療保健基礎設施是關鍵的成長驅動因素。
歐洲
歐洲佔據了較大的市場佔有率,這得益於嚴格的醫療器材法規和龐大的眼科醫生群體,提高了診斷率。
亞太地區
預計亞太地區將以最高的年複合成長率成長,這主要得益於醫療保健投資的增加以及中國、印度和日本等國家龐大的患者群體。
拉丁美洲、中東和非洲
預計這些地區將實現適度成長,這主要得益於…透過改善醫療基礎設施和增加政府投資。
The global autorefractor and keratometer market was valued at USD 73.26 million in 2025 and is projected to grow from USD 77.1 million in 2026 to USD 120.19 million by 2034, registering a CAGR of 5.71% during the forecast period. North America dominated the market in 2025, supported by advanced healthcare infrastructure and strong adoption of ophthalmic diagnostic technologies.
Autorefractors and keratometers are essential ophthalmic instruments used to measure refractive errors and corneal curvature. An autorefractor evaluates how light changes as it enters the eye to determine refractive error, while a keratometer measures the curvature of the cornea. Hybrid devices, commonly known as autorefractor-keratometers (ARKs), combine both functions, offering comprehensive eye assessments in a single system.
The rising burden of ocular disorders such as hyperopia, myopia, astigmatism, cataracts, and diabetic retinopathy is significantly driving demand for advanced diagnostic equipment worldwide. Key players operating in the market include Topcon Corporation, NIDEK CO., LTD., Carl Zeiss Meditech AG, EssilorLuxottica, and CANON MEDICAL SYSTEMS CORPORATION.
Market Drivers
Rising Prevalence of Ocular Diseases
Increasing incidence of vision disorders is a major growth driver. Lifestyle changes, rising screen time, an aging population, and growing diabetic cases are contributing to higher rates of refractive errors. According to global studies, myopia cases are projected to affect nearly half of the world's population by 2050.
Governments and healthcare organizations are emphasizing early diagnosis and preventive eye care. Regular eye screening initiatives and awareness programs are increasing the utilization of autorefractors and keratometers in hospitals and clinics, thereby supporting steady market expansion.
Market Restraints
Limited Awareness and High Device Costs
Despite technological advancements, limited awareness of routine eye examinations in low- and middle-income countries restrains market growth. Additionally, high-end autorefractor models can cost over USD 25,000, making them less accessible for smaller healthcare facilities.
Affordability concerns and delayed diagnosis due to lack of awareness may limit device penetration, especially in resource-constrained regions.
Market Opportunities
Strategic Partnerships and Technological Innovation
Rising collaborations, mergers, and acquisitions among key players are creating growth opportunities. Companies are investing in R&D to develop portable and AI-integrated diagnostic devices.
For instance, Carl Zeiss Meditech AG strengthened its ophthalmic portfolio through acquisitions aimed at enhancing digital workflow and advanced diagnostics. Increasing innovation in handheld and automated devices is expected to expand product adoption across developed and emerging markets.
Market Challenges
Shortage of Skilled Ophthalmic Professionals
A shortage of trained ophthalmic technicians and specialists presents a key challenge. Workforce imbalance limits the effective utilization of advanced diagnostic equipment, particularly in rural and underserved regions. This may reduce patient access to timely eye diagnosis and treatment.
Market Trends
Integration of AI and Digital Technologies
Technological advancements are reshaping the diagnostic landscape. Modern autorefractors and keratometers now feature digital displays, automated focusing, high-resolution imaging, cloud integration, and electronic health record (EHR) compatibility.
The integration of artificial intelligence (AI) and machine learning (ML) enables real-time analytics and precision diagnostics. These innovations improve accuracy in detecting cataracts, keratoconus, and subtle corneal abnormalities, boosting adoption across ophthalmic practices.
Impact of COVID-19
The COVID-19 pandemic negatively impacted market growth due to reduced patient visits and postponed elective examinations. Several companies experienced revenue declines in 2020. However, with the resumption of healthcare services in 2021, patient visits recovered, and the market gradually returned to its pre-pandemic growth trajectory.
By Product Type
The market is segmented into autorefractor, keratometer, and hybrid devices.
The hybrid segment (ARKs) is expected to hold a dominant share due to its high accuracy and dual-function capability. The autorefractor segment is projected to witness steady growth with AI-enabled enhancements.
By Portability
Based on portability, the market is divided into tabletop and handheld devices.
The tabletop segment dominates due to its widespread use in optometric offices and hospitals. The handheld segment is growing rapidly, driven by demand for portable diagnostic solutions in mobile clinics and rural outreach programs.
By Indication
The market includes hyperopia, myopia, astigmatism, and others.
The hyperopia segment held a significant share in 2024 due to its rising prevalence among adults and children. Myopia is projected to grow steadily due to increasing digital device usage.
By End-user
The market is segmented into hospitals, ophthalmic clinics, and others.
Hospitals dominated in 2024 due to higher patient volume and access to advanced equipment. Ophthalmic clinics are expected to grow at the fastest CAGR due to increasing specialized eye care centers.
North America
North America dominated the market in 2025, with a value of USD 26.65 million. Strong reimbursement policies, rising diabetic cases, and advanced healthcare infrastructure are key growth drivers.
Europe
Europe holds a substantial share due to strict medical device regulations and a large ophthalmologist base, supporting higher diagnostic rates.
Asia Pacific
Asia Pacific is projected to grow at the fastest CAGR due to rising healthcare investments and a large patient pool in countries such as China, India, and Japan.
Latin America & Middle East & Africa
These regions are witnessing moderate growth, supported by improving healthcare infrastructure and increasing government investments.
Competitive Landscape
The market is consolidated, with leading players such as Carl Zeiss Meditech AG, Topcon Corporation, and NIDEK CO., LTD. focusing on product innovation, partnerships, and geographic expansion. Companies are emphasizing AI integration, portability, and digital connectivity to gain a competitive edge.
Conclusion
The global autorefractor and keratometer market is expected to grow steadily from USD 73.26 million in 2025 to USD 120.19 million by 2034, driven by the rising prevalence of ocular diseases, technological advancements, and increasing emphasis on early diagnosis. While high device costs and workforce shortages present challenges, expanding healthcare infrastructure, AI-enabled innovations, and growing awareness of preventive eye care will support long-term market expansion worldwide.
Segmentation By Product Type
By Portability
By Indication
By End-user
By Region